Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Peering Into Adagio Therapeutics Inc. - Common Stock's Recent Short Interest

Adagio Therapeutics Inc. - Common Stock's (NASDAQ:ADGI) short percent of float has fallen 11.69% since its last report. The company recently reported that it has 5.28 million shares sold short, which is 12.92% of all regular shares that are available for trading.

Apple Vs. Microsoft: A Race To New All-Time Highs

Apple Inc (NASDAQ: AAPL) and Microsoft Corporation (NASDAQ: MSFT) are brand names you will of course be familiar with — and two tech giants whose stock prices have moved 600% since 2015.

Here's How Much $100 Invested In Lululemon Athletica 10 Years Ago Would Be Worth Today

Here's How Much $100 Invested In Lululemon Athletica 10 Years Ago Would Be Worth Today

Lululemon Athletica (NASDAQ:LULU) has outperformed the market over the past 10 years by 4.41% on an annualized basis producing an average annual return of 16.94%. Currently, Lululemon Athletica has a market capitalization of $47.43 billion.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Expert Ratings For Costco Wholesale

Within the last quarter, Costco Wholesale (NASDAQ:COST) has observed the following analyst ratings:

Earnings Preview: Walgreens Boots Alliance

Walgreens Boots Alliance (NASDAQ:WBA) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Walgreens Boots Alliance will report an earnings per share (EPS) of $1.38.

Rail Vision Ltd IPOs Tomorrow, Here's What You Need To Know

Rail Vision Ltd (NASDAQ:RVSN) IPO will take place March, 31 on the NASDAQ exchange under the ticker RVSN. The company is offering shares at an expected price between $4.13 and $5.87 per share with an insider lock-up period of 180 days ending on September 27, 2022.

Looking Into Stronghold Digital Mining's Return On Invested Capital

Stronghold Digital Mining (NASDAQ:SDIG) brought in sales totaling $17.01 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 178.56%, resulting in a loss of $17.49 million.

inkl

Read news from The Economist, FT, and more,
with one subscription

Microvast Holdings's Return On Capital Employed Insights

Microvast Holdings's Return On Capital Employed Insights

According to Benzinga Pro data, during Q4, Microvast Holdings (NASDAQ:MVST) posted sales of $48.12 million. Earnings were up 59.96%, but Microvast Holdings still reported an overall loss of $46.64 million.

Looking Into SenesTech's Return On Capital Employed

Looking Into SenesTech's Return On Capital Employed

SenesTech (NASDAQ:SNES) brought in sales totaling $169.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 10.7%, resulting in a loss of $2.49 million.

Urban-gro's Return On Capital Employed Insights

Urban-gro's Return On Capital Employed Insights

Benzinga Pro data, Urban-gro (NASDAQ:UGRO) reported Q4 sales of $18.96 million. Earnings fell to a loss of $604.18 thousand, resulting in a 1112.78% decrease from last quarter.

Dyadic International Earnings Perspective: Return On Capital Employed

Dyadic International Earnings Perspective: Return On Capital Employed

Dyadic International (NASDAQ:DYAI) brought in sales totaling $313.29 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 145.67%, resulting in a loss of $4.21 million.

Infinity Pharmaceuticals Earnings Perspective: Return On Capital Employed

Infinity Pharmaceuticals Earnings Perspective: Return On Capital Employed

Infinity Pharmaceuticals (NASDAQ:INFI) brought in sales totaling $451.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.76%, resulting in a loss of $11.65 million.

Looking Into HTG Molecular Diagnostics's Return On Capital Employed

Looking Into HTG Molecular Diagnostics's Return On Capital Employed

HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $2.88 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.6%, resulting in a loss of $5.19 million.

Looking Into BioCardia's Return On Capital Employed

Looking Into BioCardia's Return On Capital Employed

Benzinga Pro data, BioCardia (NASDAQ:BCDA) reported Q4 sales of $79.00 thousand. Earnings fell to a loss of $3.46 million, resulting in a 27.9% decrease from last quarter.

Get all your
news in one place.

100’s of premium titles.
One news app.

Cormedix's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q4, Cormedix's (NASDAQ:CRMD) reported sales totaled $56.40 thousand. Despite a 9.08% increase in earnings, the company posted a loss of $7.79 million.

Looking Into Sarcos Technology's Return On Capital Employed

According to Benzinga Pro data, during Q4, Sarcos Technology (NASDAQ:STRC) posted sales of $1.00 million. Earnings were up 7.9%, but Sarcos Technology still reported an overall loss of $34.06 million.

Nabriva Therapeutics's Return On Capital Employed Overview

Nabriva Therapeutics (NASDAQ:NBRV) brought in sales totaling $9.26 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 22.63%, resulting in a loss of $13.06 million.

Looking Into Sera Prognostics's Return On Capital Employed

Benzinga Pro data, Sera Prognostics (NASDAQ:SERA) reported Q4 sales of $26.00 thousand. Earnings fell to a loss of $12.48 million, resulting in a 26.63% decrease from last quarter.

Get all your
news in one place.

100’s of premium titles.
One news app.

Humacyte's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Humacyte (NASDAQ:HUMA) posted Q4 earnings of $42.59 million, an increase from Q3 of 234.92%. Sales dropped to $177.00 thousand, a 26.56% decrease between quarters.

Academy Sports Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data Academy Sports (NASDAQ:ASO) posted a 12.11% decrease in earnings from Q3. Sales, however, increased by 13.5% over the previous quarter to $1.81 billion.

Crown ElectroKinetics: Q3 Earnings Insights

Crown ElectroKinetics (NASDAQ:CRKN) reported its Q3 earnings results on Wednesday, March 30, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Kala Pharmaceuticals's Return On Capital Employed Insights

Benzinga Pro data, Kala Pharmaceuticals (NASDAQ:KALA) reported Q4 sales of $1.86 million. Earnings fell to a loss of $47.57 million, resulting in a 69.12% decrease from last quarter.

Mid-Morning Market Update: Markets Mixed; US GDP Grows 6.9% In Q4

U.S. stocks traded mixed this morning following the release of GDP data.

Berkshire Grey Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q4, Berkshire Grey's (NASDAQ:BGRY) reported sales totaled $23.59 million. Despite a 10.01% increase in earnings, the company posted a loss of $36.45 million.

Looking Into SCYNEXIS's Return On Capital Employed

SCYNEXIS (NASDAQ:SCYX) brought in sales totaling $597.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 4733.55%, resulting in a loss of $29.24 million.

1 … 745 746 747 748

Organisations

Microsoft Corporation

Walgreens Boots Alliance

Costco Wholesale

Lululemon Athletica

HTG Molecular Diagnostics

Kala Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

342,804 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play